Ketamine Enrolling by Invitation Phase 3 Trials for Suicide Threat / Suicide / Depression Severe Treatment

IndicationsStatusPurposePhase
Enrolling by InvitationTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04260607Initiating Ketamine in Acutely Suicidal Patients in the Emergency Department